期刊文献+

糖原累积病Ⅱ型20例临床及病理特点 被引量:19

Clinical and pathological features of 20 patients of glycogen storage disease type Ⅱ
原文传递
导出
摘要 目的 总结糖原累积病Ⅱ型(GSDⅡ型)的临床及病理学特点.方法 回顾性分析20例经肌肉活体组织检查病理诊断的GSDⅡ型患者的临床和病理资料,并对部分患者进行随访.结果 20例患者中婴儿型1例,表现为全身肌力、肌张力低下,肌萎缩,运动发育迟缓,喂养困难,反复肺部感染合并心功能不全,血清肌酸激酶778 IU/L,肌电图示肌源性损害,超声心动图示肥厚性心肌病;晚发型19例(少年型18例,成人型1例),表现为双侧对称性四肢近端肌萎缩或呼吸肌无力等症状,呼吸肌与肢体肌受累可不平行.15例有实验室检查记录的患者中,14例血清肌酸激酶不同程度升高(208~2600 IU/L).17例行肌电图检查,9例为肌源性损害(其中1例伴易激惹现象),4例为可疑肌源性损害,1例为肌强直样放电,1例神经源性肌源性损害合并存在,2例正常.11例行超声心动检查,发现肥厚性心肌病1例,室间隔增厚、肺动脉高压各2例.肌活体组织病理检查均以肌纤维空泡样变为主要特征,空泡形态多样,多含有嗜碱性颗粒,过碘酸Schiff反应、酸性磷酸酶染色阳性反应明显.结论 GSDⅡ型在临床上表现为慢性肌病,以躯干肌和呼吸肌受累常见.多数患者血清肌酶轻度升高,肌肉病理检查有明显空泡样变,有助于确诊. Objective To summarize the clinical and pathological features of glycogen storage disease (GSD) type Ⅱ. Methods The clinical and pathological data of the 20 GSD type Ⅱ patients were reviewed. Results One patient with infantile-onset mainly presented hypotonia, muscle weakness, feeding difficulties, pulmonary infection and cardiomyopathy insufficiency and increase of serum creatine kinase (778 IU/L) and echographic evidence of hypertrophic cardiomyopathy were detected. Electromyography studies indicated a definite myopathy. Nineteen cases were late-onset, presenting a slowly progressive proximal myopathy with truncal involvement or with symptoms dominated by respiratory insufficiency. Not all muscles were equally affected. Increase of serum creatine kinase (208-2600 IU/L) was detected in 14 patients and normal level in 1 patient. Electromyography studies indicated a definite myopathy in 9 patients,with abnormal irritability in 1 patient and susceptible in 4 patients and myotonic discharge in 1 patient and no abnormalities in 2 patients. Echographic evidence of thickening of the interventricular septum and pulmonary hypertension were detected in 2 patients respectively. The common light microscopic feature of all case was a vacuolar myopathy with high glycogen content and acid phosphatase activity in the vacuoles. Conclusions GSD type Ⅱ often presents slowly progressive myopathy which often affect the toro and respiratory muscles.In most patients the serum creatine kinase level is elevated slightly. Muscle biopsy is of use to make the definite diagnosis of this disease.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2011年第2期91-95,共5页 Chinese Journal of Neurology
关键词 糖原贮积病Ⅱ型 空泡 活组织检查 Glycogen storage disease type Ⅱ Vacuoles Muscle Biopsy
  • 相关文献

参考文献18

  • 1Kishnani PS,Corzo D,Nicolino M,et al.Recombinant human acid[alpha] -glucosidase:major clinical benefits in infantile-onset Pompe disease.Neurology,2007,68:99-109.
  • 2van der Ploeg AT,Reuser AJ.Pompe's disease.Lancet,2008,372:1343-1353.
  • 3Kishnani PS,Steiner RD,Bali D,et al.Pompe disease diagnosis and management guideline.Gent Med,2006,8:267-288.
  • 4Katzin LW,Amato AA.Pompe disease:a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.J Clin Neuromuscul Dis,2008,9:421-431.
  • 5Hermans MM,van Leenen D,Kroos MA,et al.Twenty-two novel mutation in the lysosomal alpha-glucosidase gene (GAA)underscore the genotype-phenotype correlation in glycogen storage disease type Ⅱ.Hum Mutat,2004,23:47-56.
  • 6Hagemans ML,Winkel LP,Hop WC,et al.Disease severity in children and adults with Pompe disease related to age and disease duration.Neurology,2005,64:2139-2141.
  • 7Mellies U,Stehling F,Dohna-Schwake C,et al.Respiratory failure in Pompe disease:treatment with noninvasive ventilation.Neurology,2005,64:1465-1467.
  • 8陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 9Barnes D,Hughes RA,Spencer GT.Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis.J R Soc Med,1993,86:50.
  • 10Hagemans ML,Winkel LP,Van Doom PA,et al.Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.Brain,2005,128 Pt 3:671-677.

二级参考文献35

  • 1Sahin M, duPlessis AJ. Hydrocephalus associated with glycogen storage disease type Ⅱ(Pompe's disease ). Pediatr Neurol, 1999,21:674-676.
  • 2Kretzschmar HA, Wagner H, Hubner G, et al. Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci, 1990,98 : 169-183.
  • 3Matsuoka Y, Senda Y, Hirayama M, et al. Late-onset acid mahase deficiency associated with intracranial aneurysm. Neurology, 1988,235:371-373.
  • 4Araoz C, Sun CN, Shenefelt R, et al. Glycogenosis type Ⅱ( Pompe ' s disease ) : ultrastructure of peripheral nerves. Neurology, 1974, 24:739-742.
  • 5Tsujino S, Huie M, Kanazawa N, et al. Frequent mutations in Japanese patients with acid mahase deficiency. Neuromuscul Disord,2000, 10: 599-603.
  • 6Hermans MM, van Leenen D, Kroos MA, et al. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type Ⅱ. Hum Murat, 2004, 23: 47-56.
  • 7Ausems MG, Lochman P, van Diggelen OP, et al. A diagnostic protocol for adult-onset glycogen storage disease type Ⅱ. Neurology,1999, 52: 851-853.
  • 8Umapathysivam K, Hopwood J J, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem, 2001, 47 : 1378-1383.
  • 9Hesselink RP, Wagenmakers AJ, Drost MR, et al. Lysosomal dysfunction in muscle with special reference to glycogen storage disease type Ⅱ. Biochim Biophys Acta, 2003, 1637 : 164-170.
  • 10Haley SM, Fragala MA, Skrinar AM. Pompe disease and physical disability. Dev Med Child Neural, 2003, 45: 618-623.

共引文献17

同被引文献271

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2傅立军,窦薇,周爱卿,黄美蓉,杨健萍,李奋.糖原累积病Ⅱ型的临床分析和基因学检测[J].临床儿科杂志,2006,24(12):962-965. 被引量:12
  • 3Hasan zen.Glycogen storage diseases: New perspectives[J].World Journal of Gastroenterology,2007,13(18):2541-2553. 被引量:35
  • 4Fukuda T, Ewan L, Bauer M, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol, 2006, 59 : 700-708.
  • 5Raben N, Baum R, Schreiner C, et al. Genetic suppression of autophagy dramatically enhances enzyme replacement therapy in murine Pompe disease. Clin Ther, 2010, 32(Suppl B) : S62.
  • 6Kishnani PS, Hwu WL, Mandel H, et al. A retrospective, multinational, multicenter study on the natural history of infantileonset Pompe disease. J Pediatr, 2006, 148 : 671-676.
  • 7Laforet P, Nicolino M, Eymard PB, et al. Juvenile and adult onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology, 2000, 55 : 1122-1128.
  • 8Laforet P, Petiot P, Nieolino M, et al. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology, 2008,70 : 2063-2066.
  • 9Katzin LW, Amato AA. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis, 2008,9: 421-431.
  • 10van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe' s disease : 20 original cases compared with 133 cases from the literature. Pediatrics, 2003, 112: 332- 340.

引证文献19

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部